Treatment of hypertriglyceridemia with fenofibrate, fatty acid composition of plasma and LDL, and their relations to parameters of lipoperoxidation of LDL
Annals of the New York Academy of Sciences.
2002 Jun ;
967 () :
336-41.
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
Persistent link
https://www.medvik.cz/link/pmid12079861
- MeSH
- Adult MeSH
- Fenofibrate therapeutic use MeSH
- Hypertriglyceridemia blood drug therapy MeSH
- Hypolipidemic Agents therapeutic use MeSH
- Middle Aged MeSH
- Humans MeSH
- Lipoproteins, LDL metabolism MeSH
- Fatty Acids blood metabolism MeSH
- Lipid Peroxidation * MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Fenofibrate MeSH
- Hypolipidemic Agents MeSH
- Lipoproteins, LDL MeSH
- Fatty Acids MeSH
The purpose of this study was to determine oxidation and oxidability of VLDL and LDL in connection with changes in their composition and content of FA in LDL after treatment with fenofibrate in patients with HTG.
References provided by Crossref.org
Nutrition & diabetes.
2024 Sep 11 ;
14 (1) :
73.
[epub] 20240911
Altered activities of antioxidant enzymes in patients with metabolic syndrome
